Jennifer E. Sprague, Ph.D. - Publications

Affiliations: 
2007 Washington University, Saint Louis, St. Louis, MO 
Area:
PET agents for cancer imaging

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Wadas TJ, Deng H, Sprague JE, Zheleznyak A, Weilbaecher KN, Anderson CJ. Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 1873-80. PMID 19875645 DOI: 10.2967/Jnumed.109.067140  0.607
2007 Sprague JE, Peng Y, Fiamengo AL, Woodin KS, Southwick EA, Weisman GR, Wong EH, Golen JA, Rheingold AL, Anderson CJ. Synthesis, characterization and in vivo studies of Cu(II)-64-labeled cross-bridged tetraazamacrocycle-amide complexes as models of peptide conjugate imaging agents. Journal of Medicinal Chemistry. 50: 2527-35. PMID 17458949 DOI: 10.1021/Jm070204R  0.405
2007 Sprague JE, Kitaura H, Zou W, Ye Y, Achilefu S, Weilbaecher KN, Teitelbaum SL, Anderson CJ. Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 311-8. PMID 17268030  0.518
2006 Sprague JE, Li WP, Liang K, Achilefu S, Anderson CJ. In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models. Nuclear Medicine and Biology. 33: 227-37. PMID 16546677 DOI: 10.1016/J.Nucmedbio.2005.10.011  0.569
2004 Sprague JE, Peng Y, Sun X, Weisman GR, Wong EH, Achilefu S, Anderson CJ. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 8674-82. PMID 15623652 DOI: 10.1158/1078-0432.Ccr-04-1084  0.677
Show low-probability matches.